Aclarion- Warrants (01/12/2026) Operating Income

The latest operating income for ACONW is $-7.1T as of June 2026. That compares with $-6.3M in the prior-year period — down 111401369.1% year over year. Investors often review this figure alongside Aclarion- Warrants (01/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ACONW's operating income moved from $-6.3M to $-7.1T — a 111401369.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aclarion- Warrants (01/12/2026)'s operating scale or balance-sheet position.

A operating income figure of $-7.1T for ACONW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACONW's operating income ($-7.1T), review year-over-year change from $-6.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aclarion- Warrants (01/12/2026)'s operating income against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.